Cryosite Ltd (CTE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cryosite Ltd (CTE) has a cash flow conversion efficiency ratio of 0.387x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$924.00K ≈ $653.79K USD) by net assets (AU$2.39 Million ≈ $1.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cryosite Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Cryosite Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CTE liabilities breakdown for a breakdown of total debt and financial obligations.
Cryosite Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryosite Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Waystream Holding AB (publ)
ST:WAYS
|
0.161x |
|
Duro Felguera
MC:MDF
|
0.035x |
|
Home Capital Rentals SOCIMI S.A.
MC:YHCR
|
0.020x |
|
Artea SA
PA:ARTE
|
-0.078x |
|
Aviation Links Ltd
TA:AVIA
|
0.078x |
|
Dacome International Ltd
TWO:9960
|
0.041x |
|
Woojin Plaimm
KO:049800
|
0.110x |
|
Dedicare AB (publ)
ST:DEDI
|
-0.118x |
Annual Cash Flow Conversion Efficiency for Cryosite Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Cryosite Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see CTE market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$2.39 Million ≈ $1.69 Million |
AU$2.06 Million ≈ $1.46 Million |
0.864x | -54.36% |
| 2024-06-30 | AU$1.45 Million ≈ $1.03 Million |
AU$2.74 Million ≈ $1.94 Million |
1.893x | +274.03% |
| 2023-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$1.41 Million ≈ $996.25K |
0.506x | -62.25% |
| 2022-06-30 | AU$1.86 Million ≈ $1.32 Million |
AU$2.49 Million ≈ $1.77 Million |
1.341x | +130.27% |
| 2021-06-30 | AU$819.23K ≈ $579.65K |
AU$476.96K ≈ $337.48K |
0.582x | -93.10% |
| 2020-06-30 | AU$154.88K ≈ $109.58K |
AU$1.31 Million ≈ $924.35K |
8.435x | +2135.42% |
| 2019-06-30 | AU$-1.72 Million ≈ $-1.21 Million |
AU$-647.54K ≈ $-458.17K |
0.377x | +379.99% |
| 2018-06-30 | AU$1.94 Million ≈ $1.38 Million |
AU$-261.91K ≈ $-185.32K |
-0.135x | -126.08% |
| 2017-06-30 | AU$3.15 Million ≈ $2.23 Million |
AU$1.63 Million ≈ $1.15 Million |
0.517x | +267.77% |
| 2016-06-30 | AU$3.38 Million ≈ $2.39 Million |
AU$474.61K ≈ $335.82K |
0.140x | -64.86% |
| 2015-06-30 | AU$3.54 Million ≈ $2.51 Million |
AU$1.42 Million ≈ $1.00 Million |
0.400x | +54.74% |
| 2014-06-30 | AU$6.14 Million ≈ $4.34 Million |
AU$1.58 Million ≈ $1.12 Million |
0.258x | -16.57% |
| 2013-06-30 | AU$6.26 Million ≈ $4.43 Million |
AU$1.94 Million ≈ $1.37 Million |
0.310x | -9.74% |
| 2012-06-30 | AU$5.48 Million ≈ $3.88 Million |
AU$1.88 Million ≈ $1.33 Million |
0.343x | +13.39% |
| 2011-06-30 | AU$4.69 Million ≈ $3.32 Million |
AU$1.42 Million ≈ $1.00 Million |
0.303x | +34.76% |
| 2010-06-30 | AU$4.35 Million ≈ $3.08 Million |
AU$977.66K ≈ $691.75K |
0.225x | +37.27% |
| 2009-06-30 | AU$4.34 Million ≈ $3.07 Million |
AU$709.86K ≈ $502.27K |
0.164x | -20.44% |
| 2008-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$888.27K ≈ $628.51K |
0.206x | +10.08% |
| 2007-06-30 | AU$3.74 Million ≈ $2.64 Million |
AU$697.65K ≈ $493.63K |
0.187x | +358.76% |
| 2006-06-30 | AU$2.81 Million ≈ $1.99 Million |
AU$-203.02K ≈ $-143.65K |
-0.072x | +10.55% |
| 2005-06-30 | AU$2.48 Million ≈ $1.75 Million |
AU$-199.90K ≈ $-141.44K |
-0.081x | +66.81% |
| 2004-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-738.72K ≈ $-522.69K |
-0.243x | +20.88% |
| 2002-06-30 | AU$3.89 Million ≈ $2.75 Million |
AU$-1.20 Million ≈ $-845.61K |
-0.307x | -27.31% |
| 2001-06-30 | AU$3.87 Million ≈ $2.74 Million |
AU$-933.52K ≈ $-660.52K |
-0.241x | -- |
About Cryosite Ltd
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more